GlaxoSmithKline), a pleuromutilin approved in 2008; and tigecycline (Tygacil; Pfizer), a next-generation tetracycline approved in 2005. The reasons behind the decline in antibiotic research and ...

The Federal Trade Commission in the US is planning to sue the owners of the three largest pharmacy benefits managers (PBMs) for anti-competitive behaviour, on the heels of its damning report on ...

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...

Bonus Aug 17, 1998 Sep 20, 1998 Aug 10, 1998 Bonus Ratio: 1 share(s) for every 1 shares held Rights--Feb 02, 1994 Rights ratio: 1 share for every 10 held at a price of Rs 15.0 Bonus--Jun 22, 1988 ...